BlossomHill Therapeutics, Inc. (BLSM) vs CorMedix Inc. (CRMD)

A side-by-side comparison of BlossomHill Therapeutics, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BlossomHill Therapeutics, Inc. logo
BLSM
BlossomHill Therapeutics, Inc.
$580M
$19.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CorMedix Inc. logo
CRMD
CorMedix Inc.
$570M
$7.26HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BLSM vs CRMD

growth of $100 · dividends reinvested · last 1y
BLSM +24.6% (+24.6%/yr)CRMD -3.5% (-3.5%/yr)BLSM compounded faster over this window
100120140160Start $100$125$97
BLSM CRMD

BLSM vs CRMD: by the numbers

  • •BLSM is the larger company ($580M vs $570M market cap).
  • •CRMD is profitable (40.49% net margin) while BLSM runs a net loss (0.00%).

Metrics side by side

Valuation

MetricBLSMCRMD
P/E ratioN/A3.41
Forward P/EN/A14.67
P/S ratioN/A1.23
P/B ratioN/A1.24
EV / EBITDAN/A1.82
FCF yieldN/A43.94%

Profitability

MetricBLSMCRMD
Gross margin0.00%82.78%
Operating margin0.00%46.95%
Net margin0.00%40.49%
ROEN/A40.62%
ROIC-43.41%27.87%

Growth (annualized)

MetricBLSMCRMD
Revenue CAGR (5Y)N/A352.03%
Total return CAGR (5Y)N/A9.70%

Frequently asked

Is BLSM or CRMD more profitable?
CRMD runs the higher net margin — BLSM at 0.00% versus CRMD at 40.49%.

Go deeper

Full BLSM analysisFull CRMD analysisInteractive comparison tool

Dig into the metrics

CorMedix P/E ratioBlossomHill Therapeutics ROECorMedix ROEBlossomHill Therapeutics operating marginCorMedix operating marginBlossomHill Therapeutics revenue growthCorMedix revenue growthBlossomHill Therapeutics free cash flowCorMedix free cash flow

BlossomHill Therapeutics & CorMedix appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.